1. Home
  2. PFIS vs EOLS Comparison

PFIS vs EOLS Comparison

Compare PFIS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFIS
  • EOLS
  • Stock Information
  • Founded
  • PFIS 1905
  • EOLS 2012
  • Country
  • PFIS United States
  • EOLS United States
  • Employees
  • PFIS N/A
  • EOLS N/A
  • Industry
  • PFIS Major Banks
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFIS Finance
  • EOLS Health Care
  • Exchange
  • PFIS Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • PFIS 523.7M
  • EOLS 493.5M
  • IPO Year
  • PFIS N/A
  • EOLS 2018
  • Fundamental
  • Price
  • PFIS $53.14
  • EOLS $7.55
  • Analyst Decision
  • PFIS
  • EOLS Strong Buy
  • Analyst Count
  • PFIS 0
  • EOLS 5
  • Target Price
  • PFIS N/A
  • EOLS $21.25
  • AVG Volume (30 Days)
  • PFIS 28.9K
  • EOLS 913.1K
  • Earning Date
  • PFIS 11-04-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • PFIS 4.71%
  • EOLS N/A
  • EPS Growth
  • PFIS 39.41
  • EOLS N/A
  • EPS
  • PFIS 3.35
  • EOLS N/A
  • Revenue
  • PFIS $165,604,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • PFIS $70.81
  • EOLS $14.01
  • Revenue Next Year
  • PFIS $4.92
  • EOLS $29.46
  • P/E Ratio
  • PFIS $15.63
  • EOLS N/A
  • Revenue Growth
  • PFIS 82.33
  • EOLS 17.15
  • 52 Week Low
  • PFIS $38.90
  • EOLS $5.71
  • 52 Week High
  • PFIS $59.70
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • PFIS 58.30
  • EOLS 48.83
  • Support Level
  • PFIS $52.08
  • EOLS $7.23
  • Resistance Level
  • PFIS $53.98
  • EOLS $7.75
  • Average True Range (ATR)
  • PFIS 1.03
  • EOLS 0.29
  • MACD
  • PFIS -0.01
  • EOLS 0.07
  • Stochastic Oscillator
  • PFIS 62.83
  • EOLS 47.06

About PFIS Peoples Financial Services Corp.

Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: